San Diego Blood Bank Collaborates with UC San Diego Clinical and Translational Research Institute

San Diego Blood Bank CEO David Wellis, PhD, Joins Executive Committee at CTRI

SAN DIEGO--()--The San Diego Blood Bank (SDBB), a nationally recognized blood bank and manufacturer of biological products, today announced that it is collaborating with UC San Diego Clinical and Translational Research Institute (CTRI) to support clinical trial recruitment and enrollment and increase the biorepository collection of blood samples of healthy individuals. CTRI has also welcomed David Wellis, PhD, Chief Executive Officer of SDBB to its Executive Committee leadership team.

“Our collaboration with CTRI highlights how we are growing our core business beyond conventional blood banking services and integrating into the life science research community”

As part of the SDBB and CTRI collaboration, and efforts to support clinical trials, the Community Engagement Unit at CTRI has placed iPads at the main SDBB location so that blood donors can register with ResearchMatch, a volunteer online registry funded by the National Institutes of Health that brings together researchers and volunteers who would like to be involved in research studies.

“Our collaboration with CTRI highlights how we are growing our core business beyond conventional blood banking services and integrating into the life science research community,” said David Wellis, PhD, San Diego Blood Bank Chief Executive Officer. “As a community partner organization of CTRI, we want to help ensure our community’s health and wellness by leveraging our resources and capabilities to impact basic science and clinical research. While we intend to support clinical trials, we also plan to apply for government funding of our own research into disease mechanisms and therapeutic development.”

The recently signed collaboration will also support efforts between the Translational Research Technology Unit at CTRI and the SDBB to collect and store fresh and expired blood samples for use in research. The samples will be housed in a newly created joint biorepository, which should be operational within this year. In addition, deferred donors – those who have been exposed to diseases such as malaria and cannot donate blood for a period of time – can help by volunteering to participate in clinical trials.

“I’m excited by this win-win collaboration, which has the potential to expand into additional areas that would benefit research, as well as the community, and ultimately lead to healthier lives,” said Gary S. Firestein, MD, Director of CTRI, Distinguished Professor of Medicine, Dean and Associate Vice Chancellor of Translational Medicine at UC San Diego. “I am also pleased to welcome Dr. Wellis to the CTRI Executive Committee. He has an outstanding background that bridges scientific research, biobanking, and community development, all of which will further help us accelerate laboratory discoveries into clinical treatments for patients.”

An advantage of the San Diego Blood Bank is its capability to provide control samples. The Blood Bank’s donor base has been described as “incredibly loyal” and as being made up of individuals “interested in helping.” The Blood Bank has a high volume of samples coming through the door every year and boasts 65,000 unique blood donors annually. Each month, approximately 10,000 samples are collected through six San Diego County sites and 13 Blood Mobiles, including one that makes frequent stops at UC San Diego.

About the San Diego Blood Bank

In December 1950, the San Diego Blood Bank (SDBB) was established through the support of the San Diego County Medical Society. SDBB’s mission is to provide the highest quality blood transfusion products and reference laboratory services to hospital partners throughout Southern California. We intend to further ensure the health of our community by simultaneously delivering health and wellness education and services and extending our capabilities into academic research, pre-clinical, clinical studies, and manufacturing for biotech and pharmaceutical companies. Our highly trained staff of nurses, medical technologists and quality assurance teams, and our highly accredited laboratory dictated by the U.S. Food and Drug Administration (FDA) and Current Good Manufacturing Practices (cGMP), Clinical Laboratory Improvement Amendments (CLIA), the American Association of Blood Banks (AABB), and the European Union (EU) regulatory requirements collects and processes blood from over 10,000 donors a month. The SDBB also has a Cell Therapy Laboratory that includes cord blood collection, processing and storage, and is soon to be expanded to include additional services. As a founding member of the National Blood Collaborative, the SDBB has access to donors, blood, and blood components across the U.S. For more information about the SDBB, please visit


San Diego Blood Bank
Business Development Contact:
Nalini Murdter, PhD, MBA
Chief Business Officer
Media Contact:
Maurissa Messier